Publications by authors named "Knut J Labori"

Claim this Profile
A
Association between baseline quality of life and survival in patients with non-metastatic, advanced pancreatic cancer.
Gyda G Christiansen, Ingvild Farnes, Marianne J Hjermstad, Knut Jørgen Labori

Scand J Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of postoperative pancreatic fistula after left pancreatectomy: international multicentre cohort study.
Akseli Bonsdorff, William Yu, Jakob Kirkegård, Charles de Ponthaud, Trond Kjeseth, Knut J Labori

BJS Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of neoadjuvant therapy on short-term outcomes after left pancreatectomy: A propensity score-matched international multicenter study.
Akseli Bonsdorff, Trond Kjeseth, Mushegh Sahakyan, Jakob Kirkegård, Charles de Ponthaud, Knut J Labori

Surgery· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative Hyperamylasemia (POH) Is an Early Predictor of Pancreatic Fistula Occurrence and Severity After Distal Pancreatectomy: Results from a European Multicentric Study.
Giampaolo Perri, Elisa Romandini, Giovanni Marchegiani, Poya Ghorbani, Musheg Sahakyan, Knut Jørgen Labori

Ann Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study.
Thomas F Stoop, Y H Andrew Wu, Atsushi Oba, Mahsoem Ali, Isabel M Feld, Knut J Labori

Br J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Ingvild Farnes, Caroline S Verbeke, Dyre Kleive, Anne Waage, Tore Tholfsen, Knut Jørgen Labori

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a nationwide program for total pancreatectomy and islet autotransplantation in chronic pancreatitis: A Scandinavian single-center observational study.
Anne Waage, Ammar Khan, Knut Jørgen Labori, Kåre Inge Birkeland, Hanne Scholz

Scand J Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anatomical Classification and Staging Systems of Borderline Resectable and Locally Advanced Pancreatic Cancer-A Subgroup Analysis of the NORPACT-2 Trial.
Jacob Ghotbi, Ingvild Farnes, Dyre Kleive, Caroline Verbeke, Aart Issa Epe, Knut Jørgen Labori

Ann Surg Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: From BRPC to LAPC-Rethinking Resectability in Pancreatic Cancer.
Jacob Ghotbi, Ingvild Farnes, Knut Jørgen Labori

Ann Surg Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and monitoring potential of circulating tumor DNA in resectable pancreatic cancer.
Knut Jørgen Labori

Transl Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX.
Ingmar F Rompen, Thomas F Stoop, Stijn van Roessel, Eran van Veldhuisen, Quisette P Janssen, Knut J Labori

Ann Surg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX.
Thomas F Stoop, Toshitaka Sugawara, Atsushi Oba, Isabel M Feld, Stijn van Roessel, Knut J Labori

JAMA Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model.
Akseli Bonsdorff, Trond Kjeseth, Jakob Kirkegård, Charles de Ponthaud, Poya Ghorbani, Knut J Labori

Br J Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer.
Manoj Amrutkar, Sander Johannes Thorbjørnsen Guttorm, Anette Vefferstad Finstadsveen, Knut Jørgen Labori, Lars Eide

Mol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial.
Michael Ghadimi, Uwe Pelzer, Marc G Besselink, Jens Siveke, Ralph Telgmann, Knut Jørgen Labori

BMC Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indole 3-acetate and response to therapy in borderline resectable or locally advanced pancreatic cancer.
Peder R Braadland, Ingvild Farnes, Elin H Kure, Sheraz Yaqub, Adrian McCann, Knut Jørgen Labori

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular testing for personalized therapy is underutilized in patients with borderline resectable and locally advanced pancreatic cancer - real world data from the NORPACT-2 study.
Ingvild Farnes, Marius Lund-Iversen, Lars Aabakken, Caroline Verbeke, Knut Jørgen Labori

Scand J Gastroenterol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance after surgery for pancreatic cancer: a global scoping review of guidelines and a nordic Survey of contemporary practice.
Daniel Ansari, Kjetil Søreide, Bodil Andersson, Carsten Palnæs Hansen, Hanna Seppänen, Knut Jørgen Labori

Scand J Gastroenterol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy.
Thomas F Stoop, Atsushi Oba, Y H Andrew Wu, Laurel E Beaty, Kathryn L Colborn, Knut J Labori

JAMA Netw Open· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NORPACT-1: implications for future trials - Authors' reply.
Knut Jørgen Labori, Svein Olav Bratlie, Svein Dueland, Kristoffer Lassen

Lancet Gastroenterol Hepatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance and safety of diagnostic EUS FNA/FNB and therapeutic ERCP in patients with borderline resectable and locally advanced pancreatic cancer - results from a population-based, prospective cohort study.
Ingvild Farnes, Vemund Paulsen, Caroline Sofie Verbeke, Christer Julseth Tønnesen, Lars Aabakken, Knut Jørgen Labori

Scand J Gastroenterol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic duct occlusion with polychloroprene-based glue for the management of postoperative pancreatic fistula after pancreatoduodenectomy-an outdated approach?
Sheraz Yaqub, Bård Røsok, Ivar Prydz Gladhaug, Knut Jørgen Labori

Front Surg· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson, Jon-Helge Angelsen, Christina Biörserud

Lancet Gastroenterol Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Coeliac and Hepatic Artery Aneurysms: An Experience of 84 Cases.
Ammar Khan, Bjarte Fosby, Knut J Labori, Jacopo Lanari, Eric Dorenberg

Eur J Vasc Endovasc Surg· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).
Ingvild Farnes, Dyre Kleive, Caroline S Verbeke, Lars Aabakken, Aart Issa-Epe, Knut J Labori

BJS Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis